AU2002212327A1 - Pharmaceutical preparation comprised of milk-thistle and terpenes - Google Patents

Pharmaceutical preparation comprised of milk-thistle and terpenes

Info

Publication number
AU2002212327A1
AU2002212327A1 AU2002212327A AU1232702A AU2002212327A1 AU 2002212327 A1 AU2002212327 A1 AU 2002212327A1 AU 2002212327 A AU2002212327 A AU 2002212327A AU 1232702 A AU1232702 A AU 1232702A AU 2002212327 A1 AU2002212327 A1 AU 2002212327A1
Authority
AU
Australia
Prior art keywords
thistle
terpenes
milk
pharmaceutical preparation
preparation comprised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212327A
Inventor
Heinz-Walter Joseph
Reinhard Marz
Walter Schwankl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionorica AG
Original Assignee
Bionorica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionorica AG filed Critical Bionorica AG
Publication of AU2002212327A1 publication Critical patent/AU2002212327A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002212327A 2000-10-27 2001-10-18 Pharmaceutical preparation comprised of milk-thistle and terpenes Abandoned AU2002212327A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10053384A DE10053384A1 (en) 2000-10-27 2000-10-27 Pharmaceutical preparation made from milk thistle and terpenes
DE10053384 2000-10-27
PCT/EP2001/012050 WO2002034275A1 (en) 2000-10-27 2001-10-18 Pharmaceutical preparation comprised of milk-thistle and terpenes

Publications (1)

Publication Number Publication Date
AU2002212327A1 true AU2002212327A1 (en) 2002-05-06

Family

ID=7661329

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212327A Abandoned AU2002212327A1 (en) 2000-10-27 2001-10-18 Pharmaceutical preparation comprised of milk-thistle and terpenes

Country Status (3)

Country Link
AU (1) AU2002212327A1 (en)
DE (1) DE10053384A1 (en)
WO (1) WO2002034275A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10256774A1 (en) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Medicament for transmucosal or transdermal drug administration, containing combination of monoterpene and polyol, e.g. menthol and propanediol, as resorption improvers
US6913769B2 (en) 2003-02-18 2005-07-05 Brian Douglas Oslick Compositions for prevention and treatment of symptoms associated with ethyl alcohol consumption
CN100402023C (en) * 2003-06-21 2008-07-16 山东绿叶天然药物研究开发有限公司 Legalon soft capsule and its preparing method
FR2916637B1 (en) * 2007-06-04 2010-03-12 Martine Walther NATURAL TREATMENT OF ALCOHOL DEINTOXICATION, PROGRESSIVE WEANING, TOTAL LONG-TERM ABSTINENCE. PREVENTION OF CANCER IN HIS MEASURES, HEPATITIS C, CIRRHOSIS AND CARDIOVASCULAR DIABETES
EP2184069A1 (en) * 2008-11-10 2010-05-12 Martine Walther Natural alcohol detoxication treatment, gradual weaning with long-term complete abstinence.
CN111841501A (en) * 2020-06-23 2020-10-30 五邑大学 Pharmaceutical composition for treating inflammatory diseases and application thereof
CN117919256B (en) * 2024-03-25 2024-05-24 潍坊众邦制药有限公司 Use of a composition containing pharmaceutically acceptable sterol active substances for treating hepatitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864484A (en) * 1972-05-27 1975-02-04 Madaus & Co Dr Therapeutic compositions and methods using silymarin comprising poly-hydroxyphenyl chromanones
DE2450177A1 (en) * 1973-10-22 1975-04-30 Geb Doll Edith Margot Cobb Antitumour compsn. contg. terpenoid cpds - esp. novel sesquiterpene lactones from Carduus spp
DE3537656A1 (en) * 1984-11-22 1986-05-22 Dr. Madaus GmbH & Co, 5000 Köln METHOD FOR PRODUCING ISOSILYBIN-FREE SILIBININE AND MEDICINAL PRODUCTS CONTAINING SILIBININE
DE19756677A1 (en) * 1997-12-19 1999-06-24 Krewel Meuselbach Gmbh Per-oral dry plant extract

Also Published As

Publication number Publication date
WO2002034275A1 (en) 2002-05-02
DE10053384A1 (en) 2002-05-08

Similar Documents

Publication Publication Date Title
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AU2002234545A1 (en) Pharmaceutical preparation in the form of a suspension comprising an acid-labileactive ingredient
AU4218400A (en) Lyophilized solid dosage forms and methods of making
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002212327A1 (en) Pharmaceutical preparation comprised of milk-thistle and terpenes
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU6601900A (en) Silicon derivatives of fragrant, flavouring and medicinal substances
AU4876701A (en) Peptide derivatives and medicinal compositions
AU2001245950A1 (en) Preparation of deoxynucleosides
AU4543500A (en) Pharmaceutical compositions and uses
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application